Evidence map›Paper›PMID 21315068›Full record

ArticleExperimental cell research2011

Hyaluronan suppresses prostate tumor cell proliferation through diminished expression of N-cadherin and aberrant growth factor receptor signaling.

Alamelu G Bharadwaj, Nathaniel P Goodrich, Caitlin O McAtee, Katie Haferbier, Gregory G Oakley, James K Wahl, Melanie A Simpson

Abstract read
In one paragraph

Article in Experimental cell research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. HYAL-2-WWOX-SMAD4 Signaling in Cell Death and Anticancer Response.Frontiers in cell and developmental biology · 2016
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alamelu G BharadwajDepartment of Biochemistry, University of Nebraska, Lincoln, NE 68588, USA.
Nathaniel P Goodrich
Caitlin O McAtee
Katie Haferbier
Gregory G Oakley
James K Wahl
Melanie A Simpson
University of Nebraska–Lincoln · USUniversity of Nebraska Medical Center · US

Funding

SUPPRESSIVE ROLE OF TGFBETA IN METASTASIS OF COLON CANCERP20RR018759 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI JOHNSON, KEITH R · 2003 to 2011
$17.9M
Role of hyaluronan matrix in prostate cancer progressionR01CA106584 · NCI · UNIVERSITY OF NEBRASKA LINCOLN · PI SIMPSON, MELANIE A. · 2005 to 2010
$1.1M
NCI NIH HHS R01 CA106584NCRR NIH HHS P20 RR018759
6 · The paper itself

Abstract

Hyaluronan (HA) production has been functionally implicated in prostate tumorigenesis and metastasis. We previously used prostate tumor cells overexpressing the HA synthesizing enzyme HAS3 or the clinically relevant hyaluronidase Hyal1 to show that excess HA production suppresses tumor growth, while HA turnover accelerates spontaneous metastasis from the prostate. Here, we examined pathways responsible for effects of HAS3 and Hyal1 on tumor cell phenotype. Detailed characterization of cell cycle progression revealed that expression of Hyal1 accelerated cell cycle re-entry following synchronization, whereas HAS3 alone delayed entry. Hyal1 expressing cells exhibited a significant reduction in their ability to sustain ERK phosphorylation upon stimulation by growth factors, and in their expression of the cyclin-dependent kinase inhibitor p21. In contrast, HAS3 expressing cells showed prolonged ERK phosphorylation and increased expression of both p21 and p27, in asynchronous and synchronized cultures. Changes in cell cycle regulatory proteins were accompanied by HA-induced suppression of N-cadherin, while E-cadherin expression and β-catenin expression and distribution remained unchanged. Our results are consistent with a model in which excess HA synthesis suppresses cell proliferation by promoting homotypic E-cadherin mediated cell-cell adhesion, consequently signaling to elevate cell cycle inhibitor expression and suppress G1- to S-phase transition.

Indexed as

Cell ProliferationAntigens, CDbeta CateninCadherinsCell CycleCell Cycle ProteinsCell Line, TumorCyclin-Dependent KinasesEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine KinasesHumansHyaluronic AcidMaleMitogen-Activated Protein Kinase KinasesProstatic NeoplasmsAntigens, CDbeta CateninCadherinsCDH2 protein, humanCell Cycle ProteinsCyclin-Dependent KinasesExtracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine KinasesHyaluronic AcidMitogen-Activated Protein Kinase KinasesProto-Oncogene Proteins c-aktReceptors, Growth Factor

Identifiers

PMID21315068
PMCPMC3070779
OpenAlexW2074234156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.